TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $26,109,000 | -28.2% | 547,354 | -0.0% | 0.02% | -32.0% |
| Q3 2021 | $36,362,000 | -2.3% | 547,370 | +14.7% | 0.02% | 0.0% |
| Q2 2021 | $37,226,000 | +8.5% | 477,133 | +31.5% | 0.02% | 0.0% |
| Q1 2021 | $34,318,000 | -29.1% | 362,806 | -8.6% | 0.02% | -34.2% |
| Q4 2020 | $48,374,000 | +25.4% | 396,999 | -10.1% | 0.04% | +11.8% |
| Q3 2020 | $38,585,000 | +20.0% | 441,675 | -11.3% | 0.03% | +13.3% |
| Q2 2020 | $32,147,000 | +59.5% | 497,704 | +10.3% | 0.03% | +25.0% |
| Q1 2020 | $20,155,000 | -15.0% | 451,300 | +18.6% | 0.02% | +4.3% |
| Q4 2019 | $23,711,000 | +101.1% | 380,660 | +21.4% | 0.02% | +91.7% |
| Q3 2019 | $11,791,000 | – | 313,581 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |